Any thoughts to why BETonMACE patient median eGFR is so high?
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 08:02AM
|
Re: Any thoughts to why BETonMACE patient median eGFR is so high?
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 09:40AM
|
Re: ACC 2019 Abstracts
|
1
|
Resverlogix Corp.
|
Mar 21, 2019 11:59AM
|
Re: BIO CEO Slides Up
|
2
|
Resverlogix Corp.
|
Feb 13, 2019 02:10PM
|
Re: Any thoughts to why BETonMACE patient median eGFR is so high?
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 11:35AM
|
Re: Why didn't management do some phase 2's,....
|
2
|
Resverlogix Corp.
|
Jun 19, 2019 01:08PM
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 01:00PM
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 01:22PM
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 04:16PM
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
2
|
Resverlogix Corp.
|
Mar 28, 2019 04:00PM
|
Re: Top Resverlogix Shareholders
|
2
|
Resverlogix Corp.
|
Apr 02, 2019 04:59PM
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Feb 22, 2019 08:09PM
|
Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 01, 2018 06:15PM
|
Re: Third Eye and Topline
|
2
|
Resverlogix Corp.
|
Dec 19, 2018 03:43PM
|
Re: The glucose effect?
|
2
|
Resverlogix Corp.
|
Feb 21, 2019 02:45PM
|
Re: The final events.....
|
3
|
Resverlogix Corp.
|
Jan 26, 2019 02:00PM
|
Re: BIO CEO Slides Up
|
3
|
Resverlogix Corp.
|
Sep 18, 2019 03:54PM
|
AAC Poster Question on MoCA
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 05:41PM
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 05:54PM
|
Re: One point I want to make clear...
|
3
|
Resverlogix Corp.
|
Feb 15, 2019 11:47AM
|